Acetylon Pharmaceuticals' Series A - II Round

Acetylon Pharmaceuticals raised a round of funding on January 18, 2010.

Acetylon Pharmaceuticals is a provider in the development of small molecule drugs targeting epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human disease…

Articles about Acetylon Pharmaceuticals' Series A - II Round: